- Home
- EHTH vs LRMR Comparison
EHTH vs LRMR Comparison
Compare EHTH & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- LRMR
- Stock Information
- Founded
- EHTH 1997
- LRMR N/A
- Country
- EHTH United States
- LRMR United States
- Employees
- EHTH N/A
- LRMR N/A
- Industry
- EHTH Specialty Insurers
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- EHTH Finance
- LRMR Health Care
- Exchange
- EHTH Nasdaq
- LRMR Nasdaq
- Market Cap
- EHTH 176.1M
- LRMR 183.8M
- IPO Year
- EHTH 2006
- LRMR N/A
- Fundamental
- Price
- EHTH $4.43
- LRMR $2.42
- Analyst Decision
- EHTH Hold
- LRMR Strong Buy
- Analyst Count
- EHTH 5
- LRMR 8
- Target Price
- EHTH $7.60
- LRMR $19.63
- AVG Volume (30 Days)
- EHTH 381.9K
- LRMR 1.3M
- Earning Date
- EHTH 05-07-2025
- LRMR 04-30-2025
- Dividend Yield
- EHTH N/A
- LRMR N/A
- EPS Growth
- EHTH N/A
- LRMR N/A
- EPS
- EHTH N/A
- LRMR N/A
- Revenue
- EHTH $552,565,000.00
- LRMR N/A
- Revenue This Year
- EHTH $1.75
- LRMR N/A
- Revenue Next Year
- EHTH $7.07
- LRMR N/A
- P/E Ratio
- EHTH N/A
- LRMR N/A
- Revenue Growth
- EHTH 17.04
- LRMR N/A
- 52 Week Low
- EHTH $3.58
- LRMR $1.61
- 52 Week High
- EHTH $11.36
- LRMR $11.20
- Technical
- Relative Strength Index (RSI)
- EHTH 39.97
- LRMR 55.58
- Support Level
- EHTH $4.03
- LRMR $2.12
- Resistance Level
- EHTH $5.66
- LRMR $2.33
- Average True Range (ATR)
- EHTH 0.23
- LRMR 0.18
- MACD
- EHTH 0.03
- LRMR 0.05
- Stochastic Oscillator
- EHTH 33.77
- LRMR 95.00
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.